{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:11:40Z","timestamp":1790932300011,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":4358,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1111\/j.1538-7836.2010.04089.x","type":"journal-article","created":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T16:26:34Z","timestamp":1285950394000},"page":"122-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["Recombinant human tissue factor pathway inhibitor exerts anticoagulant, anti\u2010inflammatory and antimicrobial effects in murine pneumococcal pneumonia"],"prefix":"10.1016","volume":"9","author":[{"given":"F.E.","family":"VAN DEN BOOGAARD","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"BRANDS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"SCHULTZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"LEVI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.T.H.","family":"ROELOFS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"VAN 'T VEER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"VAN DER POLL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0010","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care","volume":"29","author":"Angus","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0015","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00134-001-1143-z","article-title":"Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study","volume":"28","author":"Alberti","year":"2002","journal-title":"Intensive Care Med"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0020","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/S0140-6736(03)15021-0","article-title":"Community\u2010acquired pneumonia","volume":"362","author":"File","year":"2003","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0025","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1164\/ajrccm.161.2.9712038","article-title":"Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome","volume":"161","author":"Gunther","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0030","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/thorax.2003.013888","article-title":"Local activation of coagulation and inhibition of fibrinolysis in the lung during ventilator associated pneumonia","volume":"59","author":"Schultz","year":"2004","journal-title":"Thorax"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0035","doi-asserted-by":"crossref","first-page":"S238","DOI":"10.1097\/01.CCM.0000057849.53689.65","article-title":"Bronchoalveolar coagulation and fibrinolysis in endotoxemia and pneumonia","volume":"31","author":"Levi","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0040","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1097\/01.CCM.0000218807.20570.C2","article-title":"Local activation of the tissue factor\u2010factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia","volume":"34","author":"Rijneveld","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0045","doi-asserted-by":"crossref","first-page":"S231","DOI":"10.1097\/01.CCM.0000057848.27456.04","article-title":"Tissue factor\u2010dependent coagulation protease signaling in acute lung injury","volume":"31","author":"Ruf","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0050","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.it.2007.09.001","article-title":"Protease\u2010activated receptors: novel PARtners in innate immunity","volume":"28","author":"Shpacovitch","year":"2007","journal-title":"Trends Immunol"},{"issue":"Suppl. 6","key":"10.1111\/j.1538-7836.2010.04089.x_bb0055","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/cc7026","article-title":"Tissue factor as an initiator of coagulation and inflammation in the lung","volume":"12","author":"van der Poll","year":"2008","journal-title":"Crit Care"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0060","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1161\/ATVBAHA.107.141606","article-title":"The haemostatic role of tissue factor pathway inhibitor","volume":"28","author":"Crawley","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0065","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1182\/blood.V95.4.1124.002k20_1124_1129","article-title":"Tissue factor pathway inhibitor dose\u2010dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia","volume":"95","author":"de Jonge","year":"2000","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0070","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1172\/JCI116934","article-title":"Inhibition of endotoxin\u2010induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti\u2010tissue factor antibody in chimpanzees","volume":"93","author":"Levi","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0075","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1055\/s-0037-1613266","article-title":"Recombinant nematode anticoagulant protein c2, a novel inhibitor of tissue factor\u2010factor VIIa activity, abrogates endotoxin\u2010induced coagulation in chimpanzees","volume":"88","author":"Moons","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0080","first-page":"126","article-title":"Recombinant E.\u00a0coli\u2010derived tissue factor pathway inhibitor reduces coagulopathic and lethal effects in the baboon gram\u2010negative model of septic shock","volume":"44","author":"Carr","year":"1994","journal-title":"Circ Shock"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0085","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1172\/JCI116529","article-title":"Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock","volume":"91","author":"Creasey","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0090","first-page":"127","article-title":"Lethal E.\u00a0coli septic shock is prevented by blocking tissue factor with monoclonal antibody","volume":"33","author":"Taylor","year":"1991","journal-title":"Circ Shock"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0095","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1097\/00003246-200111000-00007","article-title":"Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo\u2010controlled, single\u2010blind, dose escalation study","volume":"29","author":"Abraham","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0100","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1001\/jama.290.2.238","article-title":"Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial","volume":"290","author":"Abraham","year":"2003","journal-title":"JAMA"},{"issue":"Suppl. 6","key":"10.1111\/j.1538-7836.2010.04089.x_bb0105","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/cc7027","article-title":"Beyond antibiotics in severe community\u2010acquired pneumonia: the role and rationale for tissue factor pathway inhibition","volume":"12","author":"Laterre","year":"2008","journal-title":"Crit Care"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0110","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/01.CCM.0000292012.87482.F4","article-title":"Antithrombin inhibits bronchoalveolar activation of coagulation and limits lung injury during Streptococcus pneumoniae pneumonia in rats","volume":"36","author":"Choi","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0115","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.4049\/jimmunol.0801199","article-title":"The receptor for advanced glycation end products impairs host defense in pneumococcal pneumonia","volume":"182","author":"van Zoelen","year":"2009","journal-title":"J Immunol"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0120","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00003246-200101000-00003","article-title":"The activity of tissue factor pathway inhibitor in experimental models of superantigen\u2010induced shock and polymicrobial intra\u2010abdominal sepsis","volume":"29","author":"Opal","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0125","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.4049\/jimmunol.172.5.3132","article-title":"Toll\u2010like receptor 2 plays a role in the early inflammatory response to murine pneumococcal pneumonia but does not contribute to antibacterial defense","volume":"172","author":"Knapp","year":"2004","journal-title":"J Immunol"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0130","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0049-3848(87)90454-3","article-title":"A sensitive assay of extrinsic coagulation pathway inhibitor (EPI) in plasma and plasma fractions","volume":"47","author":"Sandset","year":"1987","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0135","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1055\/s-0038-1661109","article-title":"Evidence for the occurrence of a fast\u2010acting inhibitor for tissue\u2010type plasminogen\u2010activator in human\u2010plasma","volume":"51","author":"Verheijen","year":"1984","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0140","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1086\/514246","article-title":"Delayed treatment with recombinant human tissue factor pathway inhibitor improves survival in rabbits with gram\u2010negative peritonitis","volume":"177","author":"Camerota","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0145","doi-asserted-by":"crossref","first-page":"L21","DOI":"10.1152\/ajplung.00155.2005","article-title":"Blockade of tissue factor\u2010factor X binding attenuates sepsis\u2010induced respiratory and renal failure","volume":"290","author":"Welty\u2010Wolf","year":"2006","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0150","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1182\/blood-2003-01-0227","article-title":"Plasminogen activator inhibitor type\u20101 deficiency does not influence the outcome of murine pneumococcal pneumonia","volume":"102","author":"Rijneveld","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0155","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1056\/NEJMra074111","article-title":"Acute lower respiratory tract infection","volume":"358","author":"Mizgerd","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0160","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0140-6736(09)61114-4","article-title":"Pathogenesis, treatment, and prevention of pneumococcal pneumonia","volume":"374","author":"van der Poll","year":"2009","journal-title":"Lancet"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0165","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1164\/ajrccm.164.10.2105027","article-title":"Coagulation blockade prevents sepsis\u2010induced respiratory and renal failure in baboons","volume":"164","author":"Welty\u2010Wolf","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0170","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1183\/09031936.00165606","article-title":"Natural anticoagulants limit lipopolysaccharide\u2010induced pulmonary coagulation but not inflammation","volume":"30","author":"Choi","year":"2007","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0175","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1164\/ajrccm.162.5.9911018","article-title":"Recombinant tissue factor pathway inhibitor reduces lipopolysaccharide\u2010induced pulmonary vascular injury by inhibiting leukocyte activation","volume":"162","author":"Enkhbaatar","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0180","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1165\/ajrcmb.26.6.4688","article-title":"Extrinsic coagulation blockade attenuates lung injury and proinflammatory cytokine release after intratracheal lipopolysaccharide","volume":"26","author":"Miller","year":"2002","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0185","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1183\/09031936.04.00140703","article-title":"Disturbed alveolar fibrin turnover during pneumonia is restricted to the site of infection","volume":"24","author":"Choi","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0190","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1086\/524873","article-title":"Role played by Toll\u2010like receptors 2 and 4 in lipoteichoic acid\u2010induced lung inflammation and coagulation","volume":"197","author":"Dessing","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0195","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1165\/rcmb.2007-0439OC","article-title":"Endogenous beta\u2010adrenergic receptors inhibit lipopolysaccharide\u2010induced pulmonary cytokine release and coagulation","volume":"39","author":"Giebelen","year":"2008","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0200","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/CCM.0b013e31819584f9","article-title":"Activation of coagulation and inhibition of fibrinolysis in the human lung on bronchial instillation of lipoteichoic acid and lipopolysaccharide","volume":"37","author":"Hoogerwerf","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0205","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1182\/blood-2009-05-199208","article-title":"Coagulation and innate immune responses: can we view them separately?","volume":"114","author":"Delvaeye","year":"2009","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0210","doi-asserted-by":"crossref","first-page":"28387","DOI":"10.1074\/jbc.M110.127019","article-title":"C\u2010terminal peptides of tissue\u2010factor pathway inhibitor are novel host defense molecules","volume":"285","author":"Papareddy","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0215","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nature06663","article-title":"Dendritic cell PAR1\u2010S1P3 signalling couples coagulation and inflammation","volume":"452","author":"Niessen","year":"2008","journal-title":"Nature"},{"key":"10.1111\/j.1538-7836.2010.04089.x_bb0220","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1086\/599097","article-title":"Fragmented tissue factor pathway inhibitor (TFPI) and TFPI C\u2010terminal peptides eliminate serum\u2010resistant Escherichia coli from blood cultures","volume":"199","author":"Schirm","year":"2009","journal-title":"J Infect Dis"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2010.04089.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622083143?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622083143?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2010.04089.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:54:01Z","timestamp":1761533641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622083143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S1538783622083143"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2010.04089.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recombinant human tissue factor pathway inhibitor exerts anticoagulant, anti\u2010inflammatory and antimicrobial effects in murine pneumococcal pneumonia","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2010.04089.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}